Professional background

Dr Anna Latorre is a Consultant Neurologist specialising in movement disorders at the National Hospital for Neurology and Neurosurgery. She also runs general neurology clinics at the same hospital. Her clinical practice covers the full spectrum of movement disorders, with a particular focus on hyperkinetic conditions such as tremor, dystonia and myoclonus, as well as Parkinson’s disease and rare movement disorders. She is experienced in the use of botulinum toxin for the treatment of movement disorders.

She completed her neurology training and PhD in clinical neuroscience at Sapienza University of Rome, with research conducted at the UCL Queen Square Institute of Neurology. She subsequently undertook advanced clinical and research training in movement disorders at Queen Square under the mentorship of under the mentorship of Professor Kailash Bhatia and Professor John Rothwell, and is currently an Honorary Associate Professor at UCL Queen Square Institute of Neurology.

Dr Latorre has an established international research profile, with over 100 peer-reviewed publications in leading international journals. She serves on the editorial boards of international journals and is actively involved in international research initiatives. She is an active member of the International Parkinson and Movement Disorders Society, contributing to clinical neurophysiology study groups and leading collaborative work on myoclonus.

Research interests

Her research focuses on the neurophysiology of movement disorders, aiming to improve diagnostic accuracy and understand disease mechanisms, particularly in hyperkinetic conditions such as tremor, dystonia and myoclonus. She also investigates non-invasive brain stimulation as a potential therapeutic approach, with the goal of translating neurophysiological insights into novel diagnostic and treatment strategies.

Languages spoken

Italian

Publications

  • Latorre A, Hale B, Cordivari C, Humaidan K, Rothwell JC, Bhatia KP, Rocchi L.
    Developing a New Method to Describe Tremor and Myoclonus. Movement Disorders. 2025.
  • Latorre A, van der Veen S, Pena A, Truong D, Erro R, Frucht S, Ganos C, Hallett M, Perez-Duenas B, Rossi M, Roze E, Vidailhet M, de Koning-Tijssen MA, Caviness JN. IAPRD new consensus classification of myoclonus. Parkinsonism and Related Disorders. 2024.
  • Latorre A, Ganos C, Hamada M, Phielipp N, Rocchi L, Merchant S, Tijssen MA, van der Veen S, Chen R.
    Diagnostic Utility of Clinical Neurophysiology in Jerky Movement Disorders: A Review from the MDS Clinical Neurophysiology Study Group. Movement Disorders Clinical Practice. 2024.
  • Pascual-Valdunciel A, Ibáñez J, Rocchi L, Song J, Rothwell JC, Bhatia KP, Farina D, Latorre A. Frequency-Selective Suppression of Essential Tremor via Transcutaneous Spinal Cord Stimulation. Movement Disorders. 2024.
  • Rocchi L, Latorre A, Menozzi E, Rispoli V, Rothwell JC, Berardelli A, Bhatia KP. Amelioration of Focal Hand Dystonia via Low-Frequency Repetitive Somatosensory Stimulation. Movement Disorders. 2024.
  • Latorre A, Rocchi L, Paparella G, Manzo N, Bhatia KP, Rothwell JC. Changes in cerebellar output abnormally modulates cortical myoclonus sensorimotor hyperexcitability. Brain. 2023.
  • Latorre A, Rocchi L, Batla A, Berardelli A, Rothwell JC, Bhatia KP. The signature of primary writing tremor is dystonic. Movement Disorders. 2021.
  • Latorre A, Cocco A, Bhatia KP, Erro R, Antelmi E, Conte A, Rothwell JC, Rocchi L. Defective somatosensory inhibition and plasticity are not required to develop dystonia. Movement Disorders. 2021.
  • Latorre A, Rocchi L, Magrinelli F, Mulroy E, Berardelli A, Rothwell JC, Bhatia KP. Unravelling the enigma of cortical tremor and other forms of cortical myoclonus. Brain. 2020.
  • Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC. The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders. Movement Disorders. 2019.
  • Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC. The use of transcranial magnetic stimulation as a treatment for movement disorders: A critical review. Movement Disorders. 2019.